Patents by Inventor Paul Wassmann

Paul Wassmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hetero-Dimeric Immunoglobulins
    Publication number: 20200024367
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Application
    Filed: February 28, 2019
    Publication date: January 23, 2020
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas BLEIN, Darko SKEGRO, Paul WASSMANN
  • PURIFICATION OF HETERO-DIMERIC IMMUNOGLOBULINS
    Publication number: 20200010568
    Abstract: The present invention describes novel hetero-dimeric immunoglobulinvariants or fragments thereof, which have reduced or eliminated binding to Protein A, Protein G or both Protein A and Protein G. Also encompassed in the present invention are methods for the selective purification of hetero-dimeric immunoglobulins or fragments thereof using Protein A and Protein G.
    Type: Application
    Filed: February 14, 2019
    Publication date: January 9, 2020
    Applicant: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Stanislas BLEIN, Fabrizio COMPER, Romain OLLIER, Paul WASSMANN
  • Hetero-Dimeric Immunoglobulins
    Publication number: 20180094077
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Application
    Filed: May 17, 2017
    Publication date: April 5, 2018
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas BLEIN, Darko Skegro, Paul Wassmann
  • Hetero-dimeric immunoglobulins
    Patent number: 9683052
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: June 20, 2017
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas Blein, Darko Skegro, Paul Wassmann
  • Hetero-dimeric immunoglobulins
    Patent number: 9683053
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: June 20, 2017
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas Blein, Darko Skegro, Paul Wassmann
  • PURIFICATION OF HETERO-DIMERIC IMMUNOGLOBULINS
    Publication number: 20150239991
    Abstract: The present invention describes novel hetero-dimeric immunoglobulinvariants or fragments thereof, which have reduced or eliminated binding to Protein A, Protein G or both Protein A and Protein G. Also encompassed in the present invention are methods for the selective purification of hetero-dimeric immunoglobulins or fragments thereof using Protein A and Protein G.
    Type: Application
    Filed: September 25, 2013
    Publication date: August 27, 2015
    Applicant: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Stanislas Blein, Fabrizio Comper, Romain Ollier, Paul Wassmann
  • Hetero-Dimeric Immunoglobulins
    Publication number: 20140187753
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Application
    Filed: January 29, 2014
    Publication date: July 3, 2014
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas Blein, Darko Skegro, Paul Wassmann
  • Hetero-Dimeric Immunoglobulins
    Publication number: 20140066599
    Abstract: The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.
    Type: Application
    Filed: March 23, 2012
    Publication date: March 6, 2014
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas Blein, Darko Skegro, Paul Wassmann